Electric vehicle manufacturer Tesla (NASDAQ:TSLA) might be the least loved Magnificent Seven member. Oddly enough, Tesla is either a pioneer or a pariah, depending on whom you ask about it. The best way to sum up Tesla’s current situation is: “It’s complicated.” Therefore, if you intend to buy Tesla stock, only purchase a few shares and have an exit plan ready if the trade goes against you.There are several issues that complicate the Tesla bull case. These issues include Tesla’s layoffs, an executive exodus ...

Companies have life cycles just like people do.Nvidia’s (NASDAQ:NVDA) fall in July told some investors this is a mature company past the peak of growth, one that will evolve into a value stock.  It’s up an astounding 2,654% over the last five years. NVDA stock can’t possibly keep rising, can it?After hitting over $130 in June, Nvidia briefly fell below $100 per share before recovering to $110. The next date to watch is Aug. 28, when it reports third quarter earnings.Before deciding whether to jump back in o ...

Tech behemoth Nvidia (NASDAQ:NVDA) stock has been taking a breather lately.  After a stellar run-up in value this year, Nvidia stock has dipped a considerable 11%. Moreover, following the correction, the stock is now trading 22.5% behind its 52-week high price of $140.76. The steep drop is linked to geopolitical, economic and company-specific factors, which are largely temporary setbacks. Given NVIDIA’s critical role as the backbone of artificial intelligence (AI), the current lull offers an excellent time ...

Market Overview - The S&P 500 has increased by 21% over the last year, but experienced a 9% decline from July 16 to August 5 due to economic instability and a drop in Japanese markets, followed by a recovery of 5% as of August 13 [1] American Express (AXP) - American Express has seen a share price increase of 44% over the past year, recently experiencing a 10% decline but is now recovering [2] - For Q2 2024, American Express reported an 8% increase in total revenue and a 39% rise in net income year-over-year, with over three million new card signups, primarily from Gen Z and millennials, who now represent about 60% of new customers [2][3] Costco Wholesale (COST) - Costco's share price has risen by 57% over the past year, with a recent 6% decline during the stock market dip, which is now recovering [5] - In Q3 of fiscal year 2024, Costco reported a 9% increase in total revenue and a 29% rise in net income year-over-year, alongside an announcement to raise membership fees from $60 to $65 for primary memberships and from $120 to $130 for executive memberships [5] Seagate Technology (STX) - Seagate Technology's share price has increased by 45% over the past year, with a 15% decline during the recent stock market dip, which is also in the process of recovery [6] - For Q4 FY 2024, Seagate reported an 18% increase in total revenue year-over-year, shifting from a net loss of $92 million in Q4 FY 2023 to a net income of $513 million in Q4 FY 2024, beating analyst predictions and providing solid guidance for Q1 FY 2025 with expected revenue of $2.1 billion [6][7]

Citi (NYSE:C) price target cuts often get outsized attention, especially considering the recent $6.4 trillion global stock market meltdown.The bank expects global GDP growth to drop to 2.2% in 2024 and then increase to 2.8% in 2025 under its “Slow Then Grow” thesis for 2024; Citi predicts the U.S. will lead the worldwide resurgence even if the economy slows down.Regarding the stock market, Citigroup projects that corporate profits will rise by 4% in 2024 and by 8% in 2025. The bank also implies that the Fed ...

Market Overview - The S&P 500 index reached a high of 5,670 in July but has shown volatility with a downward trend recently due to geopolitical tensions and sluggish GDP growth [1] - The U.S. Federal Reserve is expected to implement expansionary policies before the end of 2024, potentially leading to multiple rate cuts next year, which will support GDP growth [2] Li Auto (LI) - Li Auto's stock has corrected by 48% year-to-date, driven by negative sentiment in the EV industry and bearish views on Chinese stocks, but is considered undervalued with a forward P/E of 16.7 [4] - The company reported a cash buffer of $13.7 billion as of Q1 2024, allowing for investment in innovation and expansion [5] - Li Auto achieved a vehicle margin of 19.3% and reported a 25.5% year-on-year growth in vehicle deliveries for Q2 2024, indicating potential for a rally from oversold levels [6] Miniso Group (MNSO) - Miniso's stock has declined by 22% year-to-date, but is viewed as a buy with a forward P/E of 12.7 and a dividend yield of 2.6% [8] - The company reported a revenue growth of 26% for Q1 2024, reaching $515.7 million, with an adjusted EBITDA margin increase of 200 basis points to 25.9% [9] - Miniso plans to open 900 to 1,100 new stores annually from 2024 to 2028, expecting revenue growth at a CAGR of over 20% during this period [10] Marathon Digital (MARA) - Marathon Digital's stock is considered undervalued with a strong growth outlook, reporting a 78% year-on-year revenue growth to $145.1 million for Q2 2024 [12] - The company has an energized hash rate of 31.5 EH/s, which increased by 78% year-on-year, and expects to reach a capacity of 50 EH/s by year-end [13] - Marathon reported a liquidity buffer of $1.4 billion as of Q2 2024, providing flexibility for aggressive investments [13] IAMGOLD (IAG) - IAMGOLD's stock has surged by 110% in the last 12 months, with a forward P/E of 11, indicating attractive valuations [16] - The company is expected to benefit from higher gold prices, with gold trading at $2,460 an ounce and potential to reach $3,000 in the next 6 to 18 months [15] - IAMGOLD commenced production at the Côté Gold assets, with expectations for revenue and cash flow growth [16] Tempus AI (TEM) - Tempus AI is a new player in healthcare technology, reporting a 25% year-on-year revenue growth to $166 million for Q2 2024, with data licensing revenue increasing by 40% [19] - The company has expanded its immune-oncology portfolio and received approval for its next-generation sequencing analysis, positioning it for future growth [20] PACS Group (PACS) - PACS Group reported a 31% year-on-year revenue growth to $1.9 billion for the first half of 2024, with increased revenue and adjusted EBITDA guidance [22] - The company added 167 skilled nursing beds in Q2, and its mature facilities have an occupancy rate of 94.2%, supporting robust revenue growth [23] Cronos (CRON) - Cronos reported a 46% year-on-year revenue growth to $27.8 million for Q2 2024, supported by new market expansions [25] - The company has a cash buffer of $848 million, providing flexibility for growth initiatives [24] - Cronos is expected to achieve EBITDA break-even by 2025, indicating potential for significant stock appreciation [26]

With the current market volatility, knowing which biotech stocks to buy on the dip can lead to lucrative returns as the industry is likely to recover faster than the market average. After all, many of the most prominent biomedical developers see their stock price rise or fall based on their drug success.That’s because no matter the market conditions, the critical medicines produced by biotech companies remain in demand by the patient populations that rely on them. For example, the price of insulin, no matte ...

Everything looked like it was coming undone last week. As recession fears gripped the market, the S&P 500 tumbled 3% in a single day. The Nasdaq 100 lost more than 1,000 points at one point, its worst loss ever, before regaining some of the lost ground.Although the situation turned markedly better by Tuesday and continued improving as the week progressed, the whipsaw event still has investors cautious. Wild swing trades can often signal a new, worse crash is coming. That’s why it’s important to prepare for ...

On the morning of August 5, the unwinding of the Yen carry trade accelerated, leading to a spike in the expected volatility index. Investors were selling and asking questions later. Even the best e-commerce stocks suffered under this carnage. That pullback has created an opportunity to buy into one of the most enduring themes of our time.The thesis for e-commerce stocks is straightforward. There has been a gradual shift from physical shopping to online shopping. After all, who doesn’t love shopping from the ...

Core Viewpoint - The global industrial automation market is expected to grow at a CAGR of 8.3% from 2024 to 2031, but the robotics sector may face challenges due to economic slowdown and reduced capital expenditures, leading to potential vulnerabilities in certain robotics stocks [1]. Group 1: Dynatrace (DT) - Dynatrace operates in the software performance niche, focusing on application performance management (APM) and cloud-native monitoring, which are critical for automation processes [3][4]. - The company holds a 3% market share in the APM market and faces stiff competition from major players like Microsoft, Amazon, Google, IBM, and Cisco, making it a candidate for selling [5]. - Despite a 19% year-over-year revenue increase in Q2 2024, net income showed minimal growth at 1.1%, indicating potential stagnation [6]. Group 2: PROCEPT Biorobotics (PRCT) - PROCEPT Biorobotics is known for its AquaBeam Robotic System, which uses waterjet technology for treating benign prostate enlargement (BPH), a condition affecting up to 90% of men over 80 [7][8]. - In Q2 2024, the company reported 47 sales of the AquaBeam system, generating $53.4 million in revenue, reflecting a 61% annual growth, but it has not yet achieved profitability [9]. - The company reported a net loss of $25.6 million, slightly higher than the previous year's loss, indicating ongoing financial challenges [10]. Group 3: Zebra Technologies (ZBRA) - Zebra Technologies connects employees with assets across various sectors, including logistics and healthcare, and made a significant acquisition of Fetch Robotics for $290 million to enhance its warehouse automation capabilities [11][12]. - Competitor Symbotic may offer better exposure in the market, as it utilizes AI-powered software for optimizing robotic operations and has established partnerships with major retail chains [13][14]. - ZBRA stock has increased nearly 20% year-to-date, priced at $320, while Symbotic's stock has decreased significantly, presenting a potential high-growth opportunity [15].